Literature DB >> 7556229

Differential and enrichment media for selective culture and recognition of yeast species from clinical material.

B Louwagie1, I Surmont, J Verhaegen, F Odds.   

Abstract

An enrichment medium was developed and evaluated for isolation of fluconazole-resistant minority yeast species in a hospital setting. The enrichment medium was made by adding fluconazole (10 micrograms/ml) to yeast nitrogen base/glucose broth. Under laboratory conditions the broth permitted detection of 20 of 20 Candida krusei isolates and 20 of 20 Candida glabrata isolates in mixtures with Candida albicans even when the Candida albicans cells outnumbered those of the other species by 1000:1. Results of culture on the enrichment medium were compared with those obtained on routine agar media and on a yeast differential agar which facilitates detection of mixed yeast species by their colony colours. Only one Candida glabrata isolate was detected on the enrichment broth but not found on routine culture of 68 yeast-positive clinical specimens. However, bacterial over-growth in some broths may have retarded the appearance of other yeast isolates. On the yeast differential agar, 20 clinical specimens were found to contain mixtures of yeast species compared with only 2 on routine culture.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556229     DOI: 10.1007/bf02114896

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  8 in total

Review 1.  Fungal infections in AIDS patients.

Authors:  B Dupont; J R Graybill; D Armstrong; R Laroche; J E Touzé; L J Wheat
Journal:  J Med Vet Mycol       Date:  1992

2.  Prophylactic fluconazole and Candida krusei infection.

Authors:  R O Casasnovas; D Caillot; E Solary; B Bonotte; P Chavanet; A Bonin; P Camerlynck; H Guy
Journal:  N Engl J Med       Date:  1992-03-26       Impact factor: 91.245

3.  Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

Authors:  J R Wingard; W G Merz; M G Rinaldi; T R Johnson; J E Karp; R Saral
Journal:  N Engl J Med       Date:  1991-10-31       Impact factor: 91.245

4.  The effect of fluconazole as prophylaxis for neutropenic patients on the isolation of Candida spp. from surveillance cultures.

Authors:  M E Ellis; S M Qadri; D Spence; M A Halim; P Ernst; H Clink; F Baillie; E B De Vol
Journal:  J Antimicrob Chemother       Date:  1994-06       Impact factor: 5.790

5.  Fluconazole in the treatment of oropharyngeal candidosis in HIV-positive patients.

Authors:  G Just-Nübling; G Gentschew; M Döhle; C Böttinger; E B Helm; W Stille
Journal:  Mycoses       Date:  1990 Sep-Oct       Impact factor: 4.377

6.  Effects of temperature on anti-Candida activities of antifungal antibiotics.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

7.  Development of resistance in candida isolates from patients receiving prolonged antifungal therapy.

Authors:  P Fan-Havard; D Capano; S M Smith; A Mangia; R H Eng
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

8.  CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.

Authors:  F C Odds; R Bernaerts
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

  8 in total
  6 in total

1.  Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes.

Authors:  A Schoofs; F C Odds; R Colebunders; M Ieven; L Wouters; H Goossens
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

2.  Evaluation of CHROMagar Candida plates.

Authors:  A M Freydiere
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

3.  Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata.

Authors:  M A Pfaller; A Houston; S Coffmann
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

4.  Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates.

Authors:  C Baumgartner; A M Freydiere; Y Gille
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

5.  Simple method for detecting fluconazole-resistant yeasts with chromogenic agar.

Authors:  T F Patterson; S G Revankar; W R Kirkpatrick; O Dib; A W Fothergill; S W Redding; D A Sutton; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

6.  Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans.

Authors:  T F Patterson; W R Kirkpatrick; S G Revankar; R K McAtee; A W Fothergill; D I McCarthy; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.